Recall: D-0523-2025

Class II - Potentially Harmful

Class IIClassification

2025-06-20Initiated

OngoingStatus

ACCORD HEALTHCARE, INC.Firm

Product

Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), 1000-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-455-17

Reason

Subpotent Drug: Assay below the approved specification

Distribution

Nationwide in the USA

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.